Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Teva Pharmaceutical Industries Ltd ADR buy Truist Financial Co.

Start price
€15.95
28.05.25 / 50%
Target price
€22.09
28.05.26
Performance (%)
59.87%
Price
€25.50
07:35
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Teva Pharmaceutical Industries Ltd ADR has seen massive gains of 59.87%. This prediction currently runs until 28.05.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Teva Pharmaceutical Industries Ltd ADR 3.673% 3.673%
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

Comments by Truist_Financial_Co_ for this prediction

In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Prediction Buy
Perf. (%) 59.87%
Target price 22.090
Change
Ends at 28.05.26

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $25.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat